Aspartic peptidase inhibitors: implications in drug development.

Abstract

The last decade has witnessed an effervescence of research interest in the development of potent inhibitors of various aspartic peptidases. As an enzyme family, aspartic peptidases are relatively a small group that has received enormous interest because of their significant roles in human diseases like involvement of renin in hypertension, cathepsin D in… (More)

Topics

  • Presentations referencing similar topics